(1'R,2'R,3'R,4'R)-2-AMINO-6-CHLORO-9-[3'-ACETOXY-4'-(ACETOXYMETHYL)-2'-BROMOCYCLOPENTAN-1'-YL]-PURINE
Compound with spectra: 1 NMR
![(1'R,2'R,3'R,4'R)-2-AMINO-6-CHLORO-9-[3'-ACETOXY-4'-(ACETOXYMETHYL)-2'-BROMOCYCLOPENTAN-1'-YL]-PURINE](/api/compound/A7ukF9M5Oa9.png?ph=true&h=300&w=458 "(1'R,2'R,3'R,4'R)-2-AMINO-6-CHLORO-9-[3'-ACETOXY-4'-(ACETOXYMETHYL)-2'-BROMOCYCLOPENTAN-1'-YL]-PURINE")
| SpectraBase Compound ID | A7ukF9M5Oa9 |
|---|---|
| InChI | InChI=1S/C15H17BrClN5O4/c1-6(23)25-4-8-3-9(10(16)12(8)26-7(2)24)22-5-19-11-13(17)20-15(18)21-14(11)22/h5,8-10,12H,3-4H2,1-2H3,(H2,18,20,21)/t8-,9-,10-,12-/m0/s1 |
| InChIKey | HUQNEOVMLLQSIZ-GMOBBJLQSA-N |
| Mol Weight | 446.69 g/mol |
| Molecular Formula | C15H17BrClN5O4 |
| Exact Mass | 445.015245 g/mol |
| Enantiomer InChIKey | HUQNEOVMLLQSIZ-DNRKLUKYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(3aR,4S,6R,6aS)-6-(6-chloranylpurin-9-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol
(3aR,4S,6R,6aS)-6-(6-methoxy-9-purinyl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol
[(1R,2R,3R,4R)-4-(6-aminopurin-9-yl)-2,3-bis(phenylmethoxy)cyclopentyl]methanol
GUANOSINE-5'-METHYLENEBIS-(PHOSPHONATE)
2-N-(1-Adamantyl)-6-O-allyl-2'-deoxyganosine
(1R,2S,3R,5R)-3-[5,7-Bis(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-3-yl]-5-(hydroxymethyl)cyclopentane-1,2-diol
p-{2-{[2-amino-9-(beta-D-ribofuranosyl)-9H-purin-6-yl]amino}ethyl}-phenol, monohydrate
2,6-DIAMINO-9-(2-AZIDO-2-DEOXY-BETA-D-ARABINOFURANOSYL)-PURINE
5'-O-(4,4'-DIMETHOXYTRITYL)-6-O-HEXYL-2'-DEOXYGUANOSINE
3'-O-LEVULINYL-2'-O-METHYLADENOSINE
| Title | Journal or Book | Year |
|---|---|---|
| Facile conversion of 4-endo-hydroxy-2-oxabicyclo[3.3.0]oct-7-en-3-one into carbocyclic 2′-deoxyribonucleoside analogues | Journal of the Chemical Society, Perkin Transactions 1 | 1999 |